Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Wada

Showing results (991-1000 of 1,036) with videos related to

Pageof 104
Sort By:
American Journal of Hematology|August 1, 1997
Increased tissue factor pathway inhibitor in patients with acute myocardial infarctionY Kamikura, H Wada, A Yamada, et al.
Cancer Research|December 11, 1997
Molecular evidence that most but not all carcinosarcomas of the uterus are combination tumorsH Wada, T Enomoto, M Fujita, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|July 10, 2001
Plasma levels of total plasminogen activator inhibitor-I (PAI-I) and tPA/PAI-1 complex in patients with disseminated intravascular coagulation and thrombotic thrombocytopenic purpuraR Watanabe, H Wada, Y Miura, et al.
Bone Marrow Transplantation|January 19, 2011
Immune recovery after autologous PBSC transplantation without in vitro graft manipulation for refractory systemic lupus erythematosusH Wada, K Terasako, Y Kamiya, et al.
American Journal of Hematology|November 14, 2000
Increased plasma levels of tissue factor pathway inhibitor-activated factor X complex in patients with disseminated intravascular coagulationY Okugawa, H Wada, T Noda, et al.
Journal of Thrombosis and Haemostasis : JTH|February 6, 2013
Guidance for diagnosis and treatment of DIC from harmonization of the recommendations from three guidelinesH Wada, J Thachil, M Di Nisio, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|November 18, 1998
Changes in plasma tissue factor pathway inhibitor levels during the clinical course of disseminated intravascular coagulationM Yamamuro, H Wada, K Kumeda, et al.
American Journal of Clinical Pathology|September 16, 2000
Immunohistochemical localization of telomerase hTERT protein and analysis of clonality in multifocal vulvar intraepithelial neoplasiaH Wada, T Enomoto, K Yoshino, et al.
The Journal of Experimental Medicine|February 7, 1998
Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopesE Jäger, Y T Chen, J W Drijfhout, et al.
Neurology|May 1, 1997
Decreased expression of full-length mRNA for cBCD541 does not correlate with spinal muscular atrophy phenotype severityH Nishio, Y Ishikawa, M J Lee, et al.
Pageof 104

Showing results (991-1000 of 1,036) with videos related to

Sort By:
Pageof 104
American Journal of Hematology|August 1, 1997
Increased tissue factor pathway inhibitor in patients with acute myocardial infarctionY Kamikura, H Wada, A Yamada, et al.
Cancer Research|December 11, 1997
Molecular evidence that most but not all carcinosarcomas of the uterus are combination tumorsH Wada, T Enomoto, M Fujita, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|July 10, 2001
Plasma levels of total plasminogen activator inhibitor-I (PAI-I) and tPA/PAI-1 complex in patients with disseminated intravascular coagulation and thrombotic thrombocytopenic purpuraR Watanabe, H Wada, Y Miura, et al.
Bone Marrow Transplantation|January 19, 2011
Immune recovery after autologous PBSC transplantation without in vitro graft manipulation for refractory systemic lupus erythematosusH Wada, K Terasako, Y Kamiya, et al.
American Journal of Hematology|November 14, 2000
Increased plasma levels of tissue factor pathway inhibitor-activated factor X complex in patients with disseminated intravascular coagulationY Okugawa, H Wada, T Noda, et al.
Journal of Thrombosis and Haemostasis : JTH|February 6, 2013
Guidance for diagnosis and treatment of DIC from harmonization of the recommendations from three guidelinesH Wada, J Thachil, M Di Nisio, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|November 18, 1998
Changes in plasma tissue factor pathway inhibitor levels during the clinical course of disseminated intravascular coagulationM Yamamuro, H Wada, K Kumeda, et al.
American Journal of Clinical Pathology|September 16, 2000
Immunohistochemical localization of telomerase hTERT protein and analysis of clonality in multifocal vulvar intraepithelial neoplasiaH Wada, T Enomoto, K Yoshino, et al.
The Journal of Experimental Medicine|February 7, 1998
Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopesE Jäger, Y T Chen, J W Drijfhout, et al.
Neurology|May 1, 1997
Decreased expression of full-length mRNA for cBCD541 does not correlate with spinal muscular atrophy phenotype severityH Nishio, Y Ishikawa, M J Lee, et al.
Pageof 104